8h ago
INNOCARE - Announcement on Convening the 2026 Semi-annual Results Briefing Meeting
INNOCARE - Announcement on Convening the 2026 Semi-annual Results Briefing Meeting
does not make any representation about the accuracy or completeness of this announcement and expressly disclaims any liability arising out of or in connection with all or any part of this announcement. We accept no liability for any loss caused by reliance on such content.
InnoCare Pharma Limited Nuocheng Jianhua Pharmaceutical Co., Ltd.
(Incorporated in the Cayman Islands with limited liability) (Stock code: 9969)
Overseas regulatory announcement
This announcement is made by InnoCheng Jianhua Pharmaceutical Co., Ltd. (the "Company") pursuant to the Securities and Exchange Commission of The Stock Exchange of Hong Kong Limited.
Made in accordance with Rule 13.10B of the Securities Listing Rules.
This is to set out the Company's "Convening of the 2026 Semi-annual Results Statement" published on the website of the Shanghai Stock Exchange.
"Announcement of the Meeting".
By order of the board of directors
Nuocheng Jianhua Pharmaceutical Co., Ltd. Chairman and Executive Director Dr. Cui Jisong
Hong Kong, August 17, 2026
As at the date of this announcement, the Board of Directors includes Dr. Cui Jisong, Chairman and Executive Director; Dr. Zhao Renbin, Executive Director; Non-executive Directors
Dr. Shi Yigong and Mr. Xie Ronggang; and independent non-executive directors Ms. Hu Lan, Dr. Dong Dandan and Professor Guan Kunliang.
A-share code: 688428 A-share abbreviation: Nuocheng Jianhua Announcement number: 2026-038 Hong Kong stock code: 09969 Hong Kong stock abbreviation: Nuocheng Jianhua
Nuocheng Jianhua Pharmaceutical Co., Ltd.
Announcement on the convening of the semi-annual performance briefing 2026
The board of directors and all directors of the company guarantee that the contents of this announcement do not contain any false records or misleading statements.
or major omissions, and shall bear legal responsibility for the authenticity, accuracy and completeness of its content in accordance with the law.
Important content reminder:
Meeting time: August 25, 2026 (Tuesday) 11:00-12:00 am
Meeting place: Shanghai Stock Exchange Roadshow Center (website: http://roadshow.sseinfo.com/)
Meeting method: Shanghai Securities Roadshow Center online interaction
Investors can invest from August 18, 2026 (Tuesday) to August 24 (Monday) 16:00
Log in to the homepage of the SSE Roadshow Center website and click on the "Question Pre-Solicitation" column or go to the company email
Ask questions at [email protected]. The company will address issues of common concern to investors at the briefing meeting answer
InnoCheng Jianhua Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") will issue an announcement on August 25, 2026.
The company's 2026 semi-annual report is provided to facilitate investors to have a more comprehensive and in-depth understanding of the company's 2026 semi-annual report.
Operating results and financial status, the company plans to discuss the results at 11:00-12:00 am on Tuesday, August 25, 2026 The 2026 semi-annual performance briefing will be held to communicate on issues of concern to investors.
- Type of briefing session
This investor briefing will be held in the form of online interaction. The company will focus on its operations in the first half of 2026.
Interact and communicate with investors on the specific results and financial indicators, and to the extent permitted by information disclosure.
Within the scope, we will answer the questions that investors are generally concerned about.
- Time and place of the briefing meeting
(1) Meeting time: August 25, 2026 (Tuesday) 11:00-12:00 am
(2) Meeting place: Shanghai Stock Exchange Roadshow Center (website: http://roadshow.sseinfo.com/)
(3) Meeting method: SSE Roadshow Center online interaction
- Participants
Chairman of the Board and Chief Executive Officer: Dr. Jisong Cui Independent non-executive director: Ms. Hu Lan
Chief Financial Officer: Mr. Fu Xin
Domestic representative for information disclosure: Ms. Yuan Bei
(If there are special circumstances, participants may make adjustments)
- How investors participate
(1) Investors can invest through the mutual
Log in to the SSE Roadshow Center (https://roadshow.sseinfo.com/) to participate in this performance presentation online.
Tomorrow, the company will respond to investors' questions in a timely manner.
(2) Investors can register from 16:00 on August 18, 2026 (Tuesday) to August 24 (Monday) Log in to the homepage of the Shanghai Certificate Roadshow Center website and click on the "Ask a Question Pre-Solicitation" column
(https://roadshow.sseinfo.com/preCallQa), depending on the event time, select this event or pass
The company's email address is [email protected] to ask questions to the company. The company will give public information to investors at the briefing meeting.
Answer the questions of concern.
- Contact persons and consultation methods
Contact person: Domestic Securities Affairs Department
Tel: 010-66609913
Email: [email protected]
- Other matters
After this investor briefing is held, investors can go to the Shanghai Stock Exchange Roadshow Center
(https://roadshow.sseinfo.com/) View the holding status and main content of this investor briefing
Capacity.
Announcement is hereby made.
Board of Directors of InnoCheng Jianhua Pharmaceutical Co., Ltd.
August 18, 2026